Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Calcium Alpha-Ketoglutarate (Ca-AKG) | NMN (Nicotinamide Mononucleotide) | |
|---|---|---|
| Category | Supplements | Supplements |
| Standard Dose | — | 500-1000mg daily |
| Timing | — | Morning on empty stomach. Sublingual absorption bypasses first-pass metabolism. |
| Cycle Duration | — | ongoing |
| Evidence Level | Moderate (healthspan), Emerging (human longevity) | moderate_human |
AKG is a TCA cycle intermediate that declines with age. Supplementation reduces inflammatory cytokines, improves stem cell function, and extends healthspan in mice. Calcium salt form provides sustained release. Also supports collagen synthesis and reduces frailty markers.
NMN is a direct biosynthetic precursor to NAD+ via the salvage pathway enzyme nicotinamide phosphoribosyltransferase (NAMPT). Elevated NAD+ activates sirtuins (SIRT1-7), PARP DNA repair enzymes, and CD38/CD157 signaling. SIRT1 activation deacetylates PGC-1alpha (mitochondrial biogenesis), FOXO transcription factors (stress resistance), and NF-kB (anti-inflammatory). NMN also enters cells via the Slc12a8 transporter, recently identified in the gut.
500-1000mg daily
Morning on empty stomach. Sublingual absorption bypasses first-pass metabolism.
ongoing
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →